Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy
December 03, 2018 16:22 ET
|
Geron Corporation
Data Reporting Median Overall Survival of 29.9 Months in High-Dose Arm Presented at the 60th American Society of Hematology Annual Meeting MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) --...
Geron Reports Updated Results from Phase 2 Portion of IMerge at the 60th American Society of Hematology Annual Meeting
December 03, 2018 06:00 ET
|
Geron Corporation
MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that updated results from Part 1 of IMerge, the Phase 2 portion of a Phase 2/3 clinical trial...
Geron to Host Analyst and Investor Event on December 10, 2018
November 28, 2018 17:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company’s analyst and investor event will take place in New York, N.Y., on Monday,...
Geron to Present at Upcoming Investor Conferences in November
November 07, 2018 16:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a...
Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events
November 01, 2018 16:05 ET
|
Geron Corporation
Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology...
Geron Announces Two Oral Presentations on Imetelstat at Upcoming American Society of Hematology Annual Meeting
November 01, 2018 06:20 ET
|
Geron Corporation
Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes and IMbark Primary Analysis in Myelofibrosis to be Presented MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Geron...
Geron to Announce Third Quarter 2018 Financial Results on November 1, 2018
October 25, 2018 06:00 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its third quarter 2018 financial results after the market closes on...
Geron Announces Discontinuation of Imetelstat Collaboration by Janssen
September 27, 2018 06:00 ET
|
Geron Corporation
Geron regains global rights to imetelstat programHighlights reported for IMerge and IMbarkGeron plans to initiate the Phase 3 portion of IMergeConference call scheduled for 8:00 a.m. ET today MENLO...
Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018
September 26, 2018 20:30 ET
|
Geron Corporation
MENLO PARK, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will host a conference call to provide an update on the imetelstat collaboration with...
Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events
July 31, 2018 16:07 ET
|
Geron Corporation
MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, 2018. Second Quarter and Year to...